IAMA Therapeutics
ItalyEntry
2025
Hold
1yr
Status
Active
Who owns IAMA Therapeutics?
IAMA Therapeutics is currently owned by Indaco Venture Partners SGR through Indaco BIO (2022 vintage), since 2025. Across its history, IAMA Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-07-23
Most recent investor
Indaco Venture Partners SGRIndaco BIO · 2022 · Life Sciences VC
2 ownership periods · full history below
Key facts
HQItaly
SectorBiotech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2022 · present
Claris Ventures SGRActive
2022 · present(4yr) · Claris Biotech I · 2020 · Life Sciences VC
More from Indaco BIO
Other portfolio companies in the same fund.
Finland
Denmark
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack IAMA Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy IAMA Therapeutics?
6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on IAMA Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue